Updates
Gabapentin
DIVISION OF PROFESSIONAL LICENSING GABAPENTIN UPDATE
FAQ sheet and updates regarding Gabapentin being a Schedule V controlled substance.
CONTROLLED SUBSTANCES ADVISORY COMMITTEE - 2023 LEGISLATIVE RECOMMENDATIONS
Letter detailing concerns regarding Gabapentin
E Prescribing
REQUIRED ELECTRONIC CS PRESCRIPTIONS
Utah Board of Pharmacy — February 2024 Newsletter.
E-PRESCRIPTION INFORMATION
Division of Purchasing and Licensing — CSD Frequently Asked Questions (FAQs).
Interstate Prescribing
INTERSTATE MEDICAL LICENSURE COMPACT
General information on which states participate and how to join.
HOW TO APPLY FOR AN INTERSTATE MEDICAL LICENSURE COMPACT LICENSE
FAQS REGARDING UTAH COMPACT LICENSE
PRESCRIBING CONTROLLED SUBSTANCES FOR PATIENTS OUT OF STATE
Telehealth Prescribing
FEDERAL TELEHEALTH
The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.
STATE TELEHEALTH
Compare state policies as you search by state and specific requirements with this resource from the National Telehealth Policy Resource Center.
Details on Utah state legislation regarding telehealth, including links to practice standards for healthcare professionals, payer policies, billing and reimbursement guidelines, and COVID-19-related waivers and temporary changes.
